Conjunctivitis secondary prevention

Conjunctivitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Conjunctivitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Case Studies
Case #1
Conjunctivitis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Conjunctivitis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Conjunctivitis secondary prevention
CDC on Conjunctivitis secondary prevention
Conjunctivitis secondary prevention in the news
Blogs on Conjunctivitis secondary prevention
Directions to Hospitals Treating Conjunctivitis
Risk calculators and risk factors for Conjunctivitis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Secondary Prevention

• Ocular prophylaxis with 0.5% erythromycin ointment, or 1% tetracycline hydrochloride be given to all newborns.
• Identify the allergen and avoid the offending antigen
• Discontinued contact lens wear